Douglas Wade Beight

This inventor holds 61 USPTO granted patents, plus 14 CIPO patents and 2 EPO patents, primarily in Pharmaceutical Agents (CPC class C07D). Top assignees: Eli Lilly and Company, Merrell Dow Pharmaceuticals, Merrell Pharmaceuticals, Inc.. Active years: 1986-2013.

USPTO Granted Patents = 61

% Patents Active = 57.4

CIPO Patents = 14 (Patent Applications = 1)

EPO Patents = 2 (Patent Applications = 1)

Average Co-Inventor Count = 4.9

ph-index = 12

Forward Citations = 411(Granted Patents)

Forward Citations (Not Self Cited) = 354(Dec 10, 2025)

Inventors with similar research interests:

Location History:

Cincinnati, OH (US) (1986 - 1999)
Frankfort, ID (US) (2004)
Indianapolis, IN (US) (2001 - 2005)
Frankfort, IN (US) (2000 - 2013)

Company Filing History:

34 out of 4,507

Eli Lilly and Company

patents

15 out of 455

Merrell Dow Pharmaceuticals

patents

5 out of 194

Merrell Pharmaceuticals, Inc.

patents

4. 4 out of 236

Hoechst Marion Roussel

patents

5. 1 out of 207

Aventis Pharmaceuticals Inc.

patents

6. 2 out of 834,307

Other

patents

Years Active: 1986-2013

Loading Chart...

Areas of Expertise:

AKT Inhibitors

Quinolinyl-Pyrrolopyrazoles

sPLA2 Inhibitors

Antithrombotic Agents

Pyrazolopyridine Derivatives

Aromatic Amides

Pyrrole Derivatives

Heterocycle Substituted Diphenyl

Substituted Tricyclics

Mercaptoacetylamides

Factor Xa Inhibitors

Matrix Metalloproteinase Inhibitors

61 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 8436002 - AKT inhibitors (2013-05-07),

2. 7834029 - Quinolinyl-pyrrolopyrazoles (2010-11-16),

3. 7405299 - Compounds as pharmaceutical agents (2008-07-29),

4. 7365066 - Pyrazolopyridine derivatives as pharmaceutical agents (2008-04-29),

5. 7265225 - Quinolinyl-pyrrolopyrazoles (2007-09-04),

6. 7129245 - Aromatic amides (2006-10-31),

7. 7087626 - Pyrrole derivatives as pharmaceutical agents (2006-08-08),

8. 6992100 - [object Object] (2006-01-31),

9. 6974831 - sPLA2 inhibitors (2005-12-13),

10. 6953788 - 3-mercaptoacetylamino-1,5-substituted-2-oxo-azepan derivatives useful as inhibitors of matrix metalloproteinase (2005-10-11),

11. 6930123 - sPLA2 inhibitors (2005-08-16),

12. 6924296 - Antithrombotic agents (2005-08-02),

13. 6916840 - Spla2 inhibitors (2005-07-12),

14. 6872743 - sPLA2 inhibitors (2005-03-29),

15. 6797723 - Heterocycle substituted diphenyl leukotriene antagonists (2004-09-28),

Title: The Inventor Douglas Wade Beight

Introduction: Douglas Wade Beight is a renowned inventor based in Frankfort, Indiana. He is known for his innovative contributions to various industries.

Latest Patents: Douglas Wade Beight holds several patents in the fields of technology and engineering, showcasing his dedication to pushing the boundaries of innovation.

Career Highlights: Throughout his career, Douglas Wade Beight has demonstrated a keen ability to transform ideas into tangible inventions that have made a significant impact. His work has been recognized for its creativity and practicality.

Collaborations: Douglas Wade Beight has collaborated with leading companies and research institutions to further develop his inventions and bring them to the market. His partnerships have been instrumental in the success of his projects.

Conclusion: Douglas Wade Beight's passion for innovation and his relentless pursuit of excellence have solidified his reputation as a prominent inventor in Frankfort, Indiana, and beyond.